TRANSCATHETER ARTERIAL EMBOLIZATION WITH CISPLATIN - APOPTOSIS IN VX2TUMOR UTERUS TRANSPLANTS

Citation
Y. Harima et al., TRANSCATHETER ARTERIAL EMBOLIZATION WITH CISPLATIN - APOPTOSIS IN VX2TUMOR UTERUS TRANSPLANTS, Anticancer research, 16(1), 1996, pp. 193-199
Citations number
20
Categorie Soggetti
Oncology
Journal title
ISSN journal
02507005
Volume
16
Issue
1
Year of publication
1996
Pages
193 - 199
Database
ISI
SICI code
0250-7005(1996)16:1<193:TAEWC->2.0.ZU;2-D
Abstract
Effects of chemoembolization with cisplatin on gynecological malignanc ies were investigated using rabbit uterine tumour. 4 weeks after inocu lation, the 35 groups, the tumour tissue specimens were taken 80 minut es, 2 days and 6 days after therapy. The tumour Pt concentration was m easured, and tissue specimens were stained with hematoxylin and eosin, apopTag stain and proliferating cell nuclear antigen (PCNA) dye. In t wo days the Pt level of tumour tissue in the transcatheter arterial ch emoembolization (TACE) group was 1.97 times more than that in the intr a-arterial (IA) infusion group (p<0.01). Apoptotic index was 1.03% in the IA group versus 5.9% in the TACE (p<0.001). The PCNA index was 86. 6% in the IA group, compared with 8.6% in the TACE group (p<0.001). Ex periments reported here revealed enhanced effects of the simultaneous action of nutrient restriction and increase concentration of drug caus ed by the vascular occlusion on cell death.